AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

IMATINIB MESYLATE

18 registrations across 5 African markets— 16 active

Markets with IMATINIB MESYLATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
Imatib 100 Capsules
Capsules
🇿🇲ZambiaCipla LtdactiveMar 2030
TYKONIB 100
TABLET, COATED; ORAL
🇿🇼ZimbabweMSN LABORATORIES PRIVATE LIMITEDactiveAug 2029
TYKONIB 400
TABLET, COATED; ORAL
🇿🇼ZimbabweMSN LABORATORIES PRIVATE LIMITEDactiveAug 2029
IMAREM
TABLET, COATED; ORAL
🇿🇼ZimbabweREMEDICA LTDactiveMay 2028
IMAREM
TABLET, COATED; ORAL
🇿🇼ZimbabweREMEDICA LTDactiveMay 2028
IMATIB
CAPSULE; ORAL
🇿🇼ZimbabweCIPLA LTDactiveDec 2027
MATIS
TABLET; ORAL
🇿🇼ZimbabweKEY ONCOLOGICS (PYT) LTDactiveDec 2027
IMATIB
CAPSULE; ORAL
🇿🇼ZimbabweCIPLA LTDactiveDec 2027
IMATINIB-100 100MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2012
IMATINIB 400MG TABLET
TABLET
🇲🇼MalawiexpiredJun 2012
TYKONIB 100
Tablet, Film-coated
🇹🇿TanzaniaMSN Laboratories Private Limitedactive
IMATINIB MESYLATE
ORAL SOLID ORDINARY CAPSULES
🇺🇬UgandaCIPLA LIMITED.active
IMATINIB MESYLATE
ORAL SOLID ORDINARY CAPSULES
🇺🇬UgandaKHANDELWAL LABORATORIES PVT LIMITEDactive
TYKONIB 400
Tablets
🇹🇿TanzaniaMSN Laboratories Private Limitedactive
IMATINIB MESYLATE
ORAL SOLID ORDINARY CAPSULES
🇺🇬UgandaKHANDELWAL LABORATORIES PVT LIMITEDactive
Imatib 100
Capsules
🇹🇿TanzaniaCipla Limitedactive
Imatib 400
Capsules
🇹🇿TanzaniaCipla Limitedactive
IMATINIB MESYLATE
ORAL SOLID ORDINARY CAPSULES
🇺🇬UgandaCIPLA LIMITED.active

IMATINIB MESYLATE in Africa — Regulatory Overview

IMATINIB MESYLATE is registered across 5 African markets with 18 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zimbabwe, Tanzania, Uganda, Malawi and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 18 registrations, 16 (89%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.